and spine spacers. Its end users include companies producing orthopedic implants, private doctors and medical facilities, hospitals and surgical facilities, and veterinary companies.

M.M.A. Tech Ltd. has developed an Acetabular liner for hip replacement arthroplasty procedures made of Polyimide MP1™ to overcome the life span problems often encountered by total arthroplasty hip surgery patients. Common complications are bone resorption and a shifting of the implant from its original position due to wear and debris from the polyethylene in use today.

The MP1™ Acetabular liner has received CE approval and M.M.A. Tech Ltd is ISO 13485 certified since October 2011.

M.M.A. Tech Ltd. is conducting a 3rd clinical study of 100 patients in New Zealand. M.M.A. Tech Ltd established a contract with a leading orthopedic company in Europe.

M.M.A. Tech Ltd. is initiating a new clinical study of 15 patients in Israel, which is already registered in ClinicalTrials.gov (NIH no. NCT02503891). The results of the clinical study will serve as a pilot for the FDA approval.

M.M.A. Tech Ltd. submitted a Master File of MP1™ for the FDA which was accepted under the No. MAF 2543 on October 2014.

M.M.A. Tech has developed an Acetabular liner for hip replacement arthroplasty procedures made of Polyimide MP1™ to overcome the life span problems often encountered by total arthroplasty hip surgery patients. Common complications are bone resorption and a shifting of the implant from its original position due to wear and debris from the polyethylene in use today.